Why is Global Health falling/rising?

As of 19-Sep, Global Health Ltd's stock is currently priced at 1,366.00, reflecting a decline of 7.2 points or 0.52%. The stock has underperformed its sector today by 0.33% and has experienced a consecutive fall over the last two days, resulting in a total decrease of 1.01% during this period. Despite a strong year-to-date performance of 26.13% and a one-year return of 24.56%, the stock has shown a slight decline of 0.35% over the past month. Key factors contributing to this recent downturn include a significant drop in investor participation, with delivery volume falling by 59.21% compared to the five-day average, indicating reduced trading interest. Although the company boasts high management efficiency and a low debt-to-equity ratio, its current valuation appears expensive relative to peers, which may be causing some investor hesitation.
Broader Market Context: In the context of the broader market, Global Health's recent performance contrasts with the Sensex, which has gained 0.88% over the past week. While the stock has outperformed the benchmark over the past year, the recent underperformance in the short term suggests that investors may be reacting to the stock's high valuation and declining trading volume. The overall market has generated negative returns of -1.96% in the last year, yet Global Health's ability to maintain a positive return indicates its resilience; however, the current price movement reflects a cautious sentiment among investors amid concerns about its valuation and recent trading activity.